Therefore, noncoding variants and single nucleotide polymorphisms (SNPs) as well as some specific haplotypes of the RET proto-oncogene have been revealed to be a potential low susceptibility loci and have a function of genetic modifying factors in HSCR pathogenesis. Here, RET is linked to Hirschsprung disease.